Progress in Neuro-Psychopharmacology & Biological Psychiatry

Last updated

Background

The journal was established in 1977 as Progress in Neuro-Psychopharmacology, obtaining its current name in 1982. [1] [2] It is published eight times per year by Elsevier. The editor-in-chief is Louis Gendron (Université de Sherbrooke). According to the Journal Citation Reports , the journal has a 2022 impact factor of 5.6. [3]

Related Research Articles

<span class="mw-page-title-main">Tetrahydrobiopterin</span> Chemical compound

Tetrahydrobiopterin (BH4, THB), also known as sapropterin (INN), is a cofactor of the three aromatic amino acid hydroxylase enzymes, used in the degradation of amino acid phenylalanine and in the biosynthesis of the neurotransmitters serotonin (5-hydroxytryptamine, 5-HT), melatonin, dopamine, norepinephrine (noradrenaline), epinephrine (adrenaline), and is a cofactor for the production of nitric oxide (NO) by the nitric oxide synthases. Chemically, its structure is that of a (dihydropteridine reductase) reduced pteridine derivative (quinonoid dihydrobiopterin).

<span class="mw-page-title-main">Neopterin</span> Chemical compound

Neopterin is an organic compound belonging to the pteridine class of heterocyclic compounds.

<i>JAMA Psychiatry</i> Academic journal

JAMA Psychiatry is a monthly peer-reviewed medical journal published by the American Medical Association. It covers research in psychiatry, mental health, behavioral sciences, and related fields. The journal was established in 1919 and was split into 2 separate journals in 1959: Archives of Neurology and Archives of General Psychiatry. In 2013, their names changed to JAMA Neurology and JAMA Psychiatry, respectively. The editor-in-chief is Dost Öngür.

<i>The EMBO Journal</i> Academic journal

The EMBO Journal is a semi-monthly peer-reviewed scientific journal focusing on full-length papers describing original research of general interest in molecular biology and related areas. The editor-in-chief is Facundo D. Batista.

<i>Nature Biotechnology</i> Peer-reviewed scientific journal

Nature Biotechnology is a monthly peer-reviewed scientific journal published by Nature Portfolio. The editor-in-chief is Barbara Cheifet who heads an in-house team of editors. The focus of the journal is biotechnology including research results and the commercial business sector of this field. Coverage includes the related biological, biomedical, agricultural and environmental sciences. Also of interest are the commercial, political, legal, and societal influences that affect this field.

Genes, Brain and Behavior is a peer-reviewed scientific journal covering research in the fields of behavioral, neural, and psychiatric genetics. It is published by Wiley-Blackwell on behalf of the International Behavioural and Neural Genetics Society. The journal was established in 2002 as a quarterly and is currently published monthly. G2B is a hybrid open access journal, but two years after publication all content is available for free online.

<i>Biological Psychiatry</i> (journal) Academic journal

Biological Psychiatry is a biweekly, peer-reviewed, scientific journal of psychiatric neuroscience and therapeutics, published by Elsevier since 1985 on behalf of the Society of Biological Psychiatry, of which it is the official journal. The journal covers a broad range of topics related to the pathophysiology and treatment of major neuropsychiatric disorders. A yearly supplement is published which contains the abstracts from the annual meeting of the Society of Biological Psychiatry.

<i>alpha</i>-Methylserotonin Chemical compound

α-Methylserotonin (αMS), also known as α-methyl-5-hydroxytryptamine (α-methyl-5-HT) or 5-hydroxy-α-methyltryptamine (5-HO-αMT), is a tryptamine derivative closely related to the neurotransmitter serotonin (5-HT). It acts as a non-selective serotonin receptor agonist and has been used extensively in scientific research to study the function of the serotonin system.

<span class="mw-page-title-main">Spiramide</span> Chemical compound

Spiramide (developmental code name AMI-193) is an experimental antipsychotic that acts as a selective 5-HT2A, 5-HT1A, and D2 receptor antagonist. It has negligible affinity for the 5-HT2C receptor.

<i>Journal of Neurogenetics</i> Academic journal

The Journal of Neurogenetics is a quarterly peer-reviewed scientific journal that covers all aspects of neurogenetics. It is published by Taylor & Francis and the editor-in-chief is Chun-Fang Wu.

<i>Journal of Autism and Developmental Disorders</i> Academic journal

The Journal of Autism and Developmental Disorders is a monthly peer-reviewed medical journal covering research on all aspects of autism spectrum disorders and related developmental disabilities. The journal was established in 1971 as the Journal of Autism and Childhood Schizophrenia, obtaining its current title in 1979. It is published by Springer Science+Business Media and the editor-in-chief is Lynn Kern Koegel.

The Journal of Clinical Psychiatry is a peer-reviewed medical journal that covers clinical psychiatry, especially depression, bipolar disorder, schizophrenia, anxiety, addiction, and attention-deficit/hyperactivity disorder, as well as several other mental disorders. It is the official journal of the American Society for Clinical Psychopharmacology and was established in 1940 as Diseases of the Nervous System, before obtaining its current name in 1979.

<span class="mw-page-title-main">Flucindole</span> Chemical compound

Flucindole is an antipsychotic with a tricyclic structure that was never marketed. It is the 6,8-difluoro derivative of cyclindole.

<i>Journal of Geriatric Psychiatry and Neurology</i> Academic journal

Journal of Geriatric Psychiatry and Neurology is a bimonthly peer-reviewed medical journal covering the fields of psychiatry and neurology in geriatric settings. The journal editor-in-chief is James M. Ellison. It was established in 1988 and is published by SAGE Publications.

The Journal of Psychiatry & Neuroscience is a bimonthly open access peer-reviewed scientific journal covering research in psychiatry and neuroscience concerning the mechanisms involved in the etiology and treatment of psychiatric disorders. The journal was established in 1976 as the Psychiatric Journal of the University of Ottawa and obtained its current title in 1991. It is published by the Canadian Medical Association and the current (2021) editors-in-chief are Paul Albert and Lena Palaniyappan.

<i>ASN Neuro</i> Academic journal

ASN Neuro is a peer-reviewed open access scientific journal covering neurochemistry. It is published by SAGE Publications on behalf of the American Society for Neurochemistry, of which it is the official journal. The founding editor-in-chief was Anthony Campagnoni, who was succeeded by Monica Carson, and then in 2018 by Douglas L. Feinstein.

<i>Arquivos de Neuro-Psiquiatria</i> Academic journal

Arquivos de Neuro-Psiquiatria is a monthly peer-reviewed medical journal covering neurology and psychiatry. It is published by the Academia Brasileira de Neurologia. Articles are published in English, with abstracts in English and Portuguese. The editors-in-chief are José Antonio Livramento and Luís dos Ramos Machado.

The Journal of Cancer Research and Clinical Oncology is a monthly peer-reviewed medical journal covering oncology. It was established in 1903 under the name Zeitschrift für Krebsforschung, and changed its name to Zeitschrift für Krebsforschung und klinische Onkologie in 1971. The journal obtained its current name in 1979. It is published by Springer Science+Business Media under a hybrid publishing model and the editor-in-chief is Klaus Hoffken.

Social Psychiatry and Psychiatric Epidemiology is a monthly peer-reviewed medical journal covering the epidemiology of psychiatric disorders. It was established in 1966 under the name Social Psychiatry, obtaining its current name in 1988. It is published by Springer Science+Business Media. The editor-in-chief is Craig Morgan. According to the Journal Citation Reports, the journal has a 2021 impact factor of 4.519.

International Clinical Psychopharmacology is a bimonthly peer-reviewed medical journal published by Wolters Kluwer Health. It covers neuropsychopharmacology and clinical psychiatry. It was established in 1986. The editor-in-chief is Alessandro Serretti.

References

  1. "Progress in Neuro-Psychopharmacology". NLM Catalog. Retrieved 12 September 2015.
  2. "Progress in Neuro-Psychopharmacology & Biological Psychiatry". NLM Catalog. Retrieved 12 September 2015.
  3. "Progress in Neuro-Psychopharmacology & Biological Psychiatry". 2022 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2023.